Cancer Vaccine
Contract arrangement announced for cGMP production of GRNVAC1 for clinical trials
Published in Gene Therapy Weekly, March 23rd, 2006
The agreement provides for the transfer of Geron's vaccine production process to Cambrex and the current good manufacturing practices (cGMP) manufacture of GRNVAC1 by Cambrex.
GRNVAC1 is a therapeutic cancer vaccine comprised of autologous dendritic cells loaded ex vivo with telomerase mRNA. In March 2005, results of the first completed phase I-II clinical trial of GRNVAC1 in metastatic prostate cancer patients was published in the Journal of Immunology (JI,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-03-23)
More Articles from Gene Therapy Weekly
- Apoptosis
Cyclin D1 overexpression induces apoptosis resistance linked to carcinoma BCL-2 - Chondrogenesis
SCRG1 is induced by glucocorticoid and stimulates chondrogenesis in vitro - Diabetes Therapy
Nuclear receptor activation improves hyperglycemia and hyperlipidemia in diabetic mice - Renal Therapy
Fibrin microbeads provide a 3D platform for kidney gene and cell therapy - Virology
Adenovirus virus-associated RNA is processed to functional interfering RNAs - Addiction Medicine
Cocaine reinforcement is attenuated by antisense-induced protein reduction - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
